Stuepp RT, Scotti FM, Melo G, Munhoz EA, Modolo F. Effects of sclerosing agents on head and neck hemangiomas: A systematic review. J Clin Exp Dent. 2019;11(11):e1033-44.

doi:10.4317/jced.56143

http://dx.doi.org/10.4317/jced.56143

____________________________________________________________________________________________________________

References

1. Dasgupta R, Fishman SJ. ISSVA classification. seminars in Pediatric surgery. Elsevier. 2014;23:158-161. https://doi.org/10.1053/j.sempedsurg.2014.06.016 PMid:25241091

2. Avila ÉDd, Molon RSd, Conte Neto N, Gabrielli MAC, Hochuli-Vieira E. Lip cavernous hemangioma in a young child. Br Dent J. 2010;21:370-374. https://doi.org/10.1590/S0103-64402010000400015 PMid:20976391

3. Oksiuta M, Matuszczak E, Debek W, Dzienis-Koronkiewicz E, Hermanowicz A. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature. J Matern Fetal Neonatal Med. 2016;29:64-68. https://doi.org/10.3109/14767058.2014.986650 PMid:25385271

4. Zheng JW, Zhang L, Zhou Q, Mai HM, Wang YA, Fan XD, et al. A practical guide to treatment of infantile hemangiomas of the head and neck. Int J Clin Exp Med. 2013;6:851. PMid:24260591

5. Hou J, Wang M, Tang H, Wang Y, Huang H. Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients. Int J Oral Maxillofac Surg. 2011;40:1246-1251. https://doi.org/10.1016/j.ijom.2011.07.906 PMid:21893396

6. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol. 2004;50:875-882. https://doi.org/10.1016/j.jaad.2003.10.670 PMid:15153887

7. North PE. Classification and Pathology of Congenital and Perinatal Vascular Anomalies of the Head and Neck. Otolaryngol Clin North Am. 2018;51:1-39. https://doi.org/10.1016/j.otc.2017.09.020 PMid:29217054

8. Adams DM, Ricci KW. Infantile Hemangiomas in the Head and Neck Region. Otolaryngol Clin North Am. 2018;51:77-87. https://doi.org/10.1016/j.otc.2017.09.009 PMid:29217069

9. Enjolras O, Mulliken J. Vascular cutaneous anomalies in children: malformations and hemangiomas. Pediatr Surg Int. 1996;11:290-295. https://doi.org/10.1007/BF00497795 PMid:24057698

10. Johann ACBR, Aguiar MCF, do Carmo MAV, Gomez RS, Castro WH, Mesquita RA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:579-584. https://doi.org/10.1016/j.tripleo.2004.12.021 PMid:16243243

11. Zweegers J, van der Vleuten CJ. The psychosocial impact of an infantile haemangioma on children and their parents. Arch Dis Child. 2012;97:922-6. PMid:22863688

12. Da Silva WB, Ribeiro ALR, de Menezes SAF, Pinheiro JdJV, de Melo Alves-Junior S. Oral capillary hemangioma: A clinical protocol of diagnosis and treatment in adults. Oral Maxillofac Surg. 2014;18:431-437. https://doi.org/10.1007/s10006-013-0436-z PMid:24263242

13. Horbach SE, Lokhorst MM, Saeed P, Rothová A, van der Horst CM. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg. 2016;69:295-304. https://doi.org/10.1016/j.bjps.2015.10.045 PMid:26723834

14. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet. 2011;377:108-109. https://doi.org/10.1016/S0140-6736(10)60903-8

15. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269, W264. https://doi.org/10.7326/0003-4819-151-4-200908180-00135 PMid:19622511

16. Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ. 2005;331:1064-1065. https://doi.org/10.1136/bmj.38636.593461.68 PMid:16230312 PMCid:PMC1283190

17. Agarwal S. Treatment of oral hemangioma with 3% sodium tetradecyl sulfate: study of 20 cases. Indian J Otolaryngol Head Neck Surg. 2012;64:205-207. https://doi.org/10.1007/s12070-011-0249-z PMid:23998020 PMCid:PMC3431531

18. Minkow B, Laufer D, Gutman D. Treatment of oral hemangiomas with local sclerosing agents. Int J Oral Surg. 1979;8:18-21. https://doi.org/10.1016/S0300-9785(79)80034-4 PMid:107130

19. Pienaar C, Graham R, Geldenhuys S, Hudson DA. Intralesional bleomycin for the treatment of hemangiomas. Plast Recontr Surg. 2006;117:221-226. https://doi.org/10.1097/01.prs.0000194906.61805.b0 PMid:16404271

20. Prado BN, dos Santos AF, Oliveira JMM, Vaccarezza GF, de Freitas CF. Uso de oleato de etanolamina para hemangiomas da cavidade bucal: um estudo de cinco anos. Revista de Odontologia da UNICID. 2011;23:42. https://doi.org/10.26843/ro_unicid.v23i1.372

21. Heit JJ, Do HM, Prestigiacomo CJ, Delgado-Almandoz JA, English J, Gandhi CD, et al. Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations. J Neurointerv Surg. 2017;9:611-617. PMid:26801946

22. Duffy DM. Sclerosants: a comparative review. Dermatol Surg. 2010;36:1010-1025. https://doi.org/10.1111/j.1524-4725.2009.01469.x PMid:20590708

23. O'Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol. 1997;169:723-729. https://doi.org/10.2214/ajr.169.3.9275886 PMid:9275886

24. Harjai MM, Jha M. Intralesional bleomycin and sodium tetradecyl sulphate for haemangiomas and lymphangiomas. Afr J Paediatr Surg. 2012;9. https://doi.org/10.4103/0189-6725.93304 PMid:22382104

25. do Monte Lameiro TM, Denadai R, Pereira-Filho JC, Raposo-Amaral CA, Raposo-Amaral CE. Treatment of Facial Infantile Hemangioma: Comparative Study Between Propranolol and Ethanolamine Oleate. J Craniofac Surg. 2018;29:1514-1517. https://doi.org/10.1097/SCS.0000000000004573 PMid:29621088

26. Luo Q-f, Zhao F-y. The effects of Bleomycin A5 on infantile maxillofacial haemangioma. Head Face Med. 2011;7:11. https://doi.org/10.1186/1746-160X-7-11 PMid:21736714 PMCid:PMC3148961

27. Qiu Y, Lin X, Ma G, Chang L, Jin Y, Chen H, et al. Eighteen Cases of Soft Tissue Atrophy After Intralesional Bleomycin A5 Injections for the Treatment of Infantile Hemangiomas: A Long-Term Follow-Up. Pediatr Dermatol. 2015;32:188-191. https://doi.org/10.1111/pde.12422 PMid:25640925

28. Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo-Hernandez H, et al. Interventions for infantile haemangiomas of the skin. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD006545.pub3 PMid:29667726 PMCid:PMC6513200

29. Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, et al. Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics. 2016;2016:e20160353. https://doi.org/10.1542/peds.2016-0353 PMid:27688361

30. Rotter A, de Oliveira ZNP. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. J Dtsch Dermatol Ges. 2017;15:1185-1190. https://doi.org/10.1111/ddg.13365 PMid:29193649

31. Price A, Rai S, Mcleod R, Birchall J, Elhassan H. Topical propranolol for infantile haemangiomas: A systematic review. J Eur Acad Dermatol Venereol. 2018;32:2083-2089. https://doi.org/10.1111/jdv.14963 PMid:29569772